Sunshine Biopharma wins Canadian approval for generic Enalapril tablets

Reuters2026/08/19 13:38

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Sunshine Biopharma won Canadian regulatory clearance for generic Enalapril tablets, expanding its cardiovascular portfolio.
Shipments to Canadian pharmacies targeted by end-2026 via subsidiary Nora Pharma’s distribution network.
Move positions the company for demand in the global anti-hypertensive market, valued at USD 25.94 billion in 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sunshine Biopharma Inc. published the original content used to generate this news brief on August 19, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Sunshine Biopharma wins Canadian approval for generic Enalapril tablets

You may also like

Crypto prices